BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 10487404)

  • 1. Treatment of xerostomia with the bile secretion-stimulating drug anethole trithione: a clinical trial.
    Hamada T; Nakane T; Kimura T; Arisawa K; Yoneda K; Yamamoto T; Osaki T
    Am J Med Sci; 1999 Sep; 318(3):146-51. PubMed ID: 10487404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical study with a sialagogue drug (sulfarlem S 25 = TTPT) in the treatment of xerostomia (author's transl)].
    Häusler R; Ritschard J
    Schweiz Rundsch Med Prax; 1979 Aug; 68(33):1063-8. PubMed ID: 471936
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical picture, diagnosis and therapy of xerostomia--attempt of a survey under pathophysiological aspects (author's transl)].
    Chilla R
    HNO; 1982 Jun; 30(6):201-7. PubMed ID: 7107333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of salivary secretion and neuropeptide (substance P, alpha-calcitonin gene-related peptide) levels in saliva by chronic anethole trithione treatment.
    Nagano T; Takeyama M
    J Pharm Pharmacol; 2001 Dec; 53(12):1697-702. PubMed ID: 11804400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of xerostomia in patients with primary Sjögren's syndrome with sulfarlem.
    Schiødt M; Oxholm P; Jacobsen A
    Scand J Rheumatol Suppl; 1986; 61():250-2. PubMed ID: 3473639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The diagnostic suitability of a xerostomia questionnaire and the association between xerostomia, hyposalivation and medication use in a group of nursing home residents.
    van der Putten GJ; Brand HS; Schols JM; de Baat C
    Clin Oral Investig; 2011 Apr; 15(2):185-92. PubMed ID: 20165967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Saliva substitutes for the treatment of radiation-induced xerostomia--a review.
    Hahnel S; Behr M; Handel G; Bürgers R
    Support Care Cancer; 2009 Nov; 17(11):1331-43. PubMed ID: 19495809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic effect of sialagogues in management of xerostomia after radiation therapy.
    Epstein JB; Schubert MM
    Oral Surg Oral Med Oral Pathol; 1987 Aug; 64(2):179-82. PubMed ID: 3306552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Sialor in treatment of xerostomia in Sjögren's syndrome.
    Epstein JB; Decoteau WE; Wilkinson A
    Oral Surg Oral Med Oral Pathol; 1983 Nov; 56(5):495-9. PubMed ID: 6358997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Xerostomia and hyposalivation: causes, consequences and treatment in the elderly.
    Närhi TO; Meurman JH; Ainamo A
    Drugs Aging; 1999 Aug; 15(2):103-16. PubMed ID: 10495070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical aspects of xerostomia.
    Remick RA; Blasberg B; Patterson BD; Carmichael RP; Miles JE
    J Clin Psychiatry; 1983 Feb; 44(2):63-5. PubMed ID: 6826533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical trials of a sialogogue in humans: a preliminary report.
    Epstein JB
    Spec Care Dentist; 1982; 2(1):17-9. PubMed ID: 6951304
    [No Abstract]   [Full Text] [Related]  

  • 13. Minor gland saliva flow rate and proteins in subjects with hyposalivation due to Sjogren's syndrome and radiation therapy.
    Eliasson L; Almståhl A; Lingström P; Wikström M; Carlén A
    Arch Oral Biol; 2005 Mar; 50(3):293-9. PubMed ID: 15740707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant chemotherapy in breast cancer patients induces temporary salivary gland hypofunction.
    Jensen SB; Mouridsen HT; Reibel J; Brünner N; Nauntofte B
    Oral Oncol; 2008 Feb; 44(2):162-73. PubMed ID: 17588802
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of homeopathic treatment on salivary flow rate and subjective symptoms in patients with oral dryness: a randomized trial.
    Haila S; Koskinen A; Tenovuo J
    Homeopathy; 2005 Jul; 94(3):175-81. PubMed ID: 16060203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systemic therapy of salivary gland hypofunction.
    Fox PC
    J Dent Res; 1987 Feb; 66 Spec No():689-92. PubMed ID: 3476633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of SL 25 on radiogenic xerostomia in the radiotherapy of tumors in the region of neck and face (author's transl)].
    Hassenstein E; Müller R; Reinhard HJ
    Strahlentherapie; 1978 Aug; 154(8):554-8. PubMed ID: 356350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of the effects of yohimbine and anetholtrithione on salivary secretion in depressed patients treated with psychotropic drugs.
    Bagheri H; Schmitt L; Berlan M; Montastruc JL
    Eur J Clin Pharmacol; 1997; 52(5):339-42. PubMed ID: 9272401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral symptoms and salivary findings in oral lichen planus, oral lichenoid lesions and stomatitis.
    Larsen KR; Johansen JD; Reibel J; Zachariae C; Rosing K; Pedersen AML
    BMC Oral Health; 2017 Jun; 17(1):103. PubMed ID: 28662707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between saliva stimulants and a saliva substitute in patients with xerostomia and hyposalivation.
    Stewart CM; Jones AC; Bates RE; Sandow P; Pink F; Stillwell J
    Spec Care Dentist; 1998; 18(4):142-8. PubMed ID: 10218061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.